Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting-Reference-Cited by-同舟云学术

Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting

Published:2019-02-04 Issue:3 Volume:53 Page:367-375
ISSN:0960-7692
Container-title:Ultrasound in Obstetrics & Gynecology
language:en
Short-container-title:Ultrasound Obstet Gynecol

Author:

Zeisler H.¹,Llurba E.²,Chantraine F. J.³,Vatish M.⁴,Staff A. C.⁵,Sennström M.⁶,Olovsson M.⁷,Brennecke S. P.⁸,Stepan H.⁹,Allegranza D.¹⁰,Schoedl M.¹¹,Grill S.¹¹,Hund M.¹⁰,Verlohren S.¹²^ORCID

Affiliation:

1. Department of Obstetrics and Gynecology; Medical University Vienna; Vienna Austria

2. Vall d'Hebron University Hospital; Universitat Autònoma de Barcelona; Barcelona Spain

3. University of Liège, CHR de la Citadelle; Liège Belgium

4. University of Oxford; Oxford UK

5. Oslo University Hospital and University of Oslo; Oslo Norway

6. Karolinska University Hospital; Stockholm Sweden

7. Uppsala University; Uppsala Sweden

8. Department of Obstetrics and Gynaecology; The University of Melbourne and Royal Women's Hospital; Melbourne Australia

9. Leipzig University; Leipzig Germany

10. Roche Diagnostics International Ltd; Rotkreuz Switzerland

11. Roche Diagnostics GmbH; Penzberg Germany

12. Charité -Universitätsmedizin; Berlin Germany

Funder

Roche Diagnostics

Publisher

Wiley

Subject

Obstetrics and Gynecology,Radiology, Nuclear Medicine and imaging,Reproductive Medicine,General Medicine,Radiological and Ultrasound Technology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/uog.19178/fullpdf

Reference22 articles.

1. Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis;Ananth;BMJ,2013

2. World Health Organization (WHO) http://www.who.int/whr/2005/en/

3. Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study;Hernández-Diaz;BMJ,2009

4. The global impact of pre-eclampsia and eclampsia;Duley;Semin Perinatol,2009

5. Changes in circulating level of angiogenic factors from first to second trimester as predictors of preeclampsia;Vatten;Am J Obstet Gynecol,2007

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does the use of angiogenic biomarkers for the management of preeclampsia and fetal growth restriction improve outcomes?: Challenging the current status quo;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-09

2. Effect of Pravastatin on Placental Expression of Epidermal Growth Factor-like Domain 7 in Early-Onset Pre-Eclampsia: A New Potential Mechanism of Action;Biomedicines;2024-08-22

3. The addition of the sFlt-1/PlGF ratio to the protein/creatinine ratio in multiple pregnancy: Post-hoc analysis of the PREPARE cohort study;Pregnancy Hypertension;2024-06

4. Screening auf Präeklampsie und Frühgeburt im ersten und zweiten Trimester;Die Gynäkologie;2024-05-23

5. Repeat Placental Growth Factor-Based Testing in Women With Suspected Preterm Preeclampsia: A Stratified Analysis of the PARROT-2 Trial;Hypertension;2024-05-06